mortality were projected by fitting a linear regression model to observed age-specific cancer rates against observed years, then multiplying the projected age-specific rates by the age-specific population. The Joinpoint regression model was used to determine at which year the linear trend changed significantly, we only used the data of the latest trend.
Introduction
As the leading cause of death in Korea [1] , cancer has been the country's major public health concern since 1983. Over 210,000 patients were newly diagnosed with cancer in Korea, and one in four deaths is due to cancer [2] . Although the cancer registration system in Korea is highly efficient and can provide nationwide cancer statistics within a relatively brief period, a lag time of at least 2 years is required to collect, and analyze of the data on a specific year. For planning and implementation of comprehensive cancer control programs, it is important to assess the number of new cases and deaths that are expected to occur during the current year. In this study, we report the projected cancer incidence and mortality for the year 2018 based on the data from the 1990s through 2016.
Materials and Methods
The Korean Ministry of Health and Welfare initiated a nationwide, hospital-based cancer registry, the Korea Central Cancer Registry (KCCR), in 1980. The history, objectives, and activities of the KCCR have been documented in detail elsewhere [3] . Incidence data from 1999 to 2015 were obtained from the Korea National Cancer Incidence Database. Cancer cases were classified according to the International Classification of Diseases for Oncology, third edition [4] , and converted according to the International Classification of Diseases, 10th edition (ICD-10) [5] . Mortality data from 1993 to 2016 were acquired from Statistics Korea [1] . The cause of death was coded and classified according to ICD-10 [5] .
The cancer sites included in this study were (1) all cancers combined and (2) the 24 common cancers as follows: lip, oral cavity, and pharynx (C00-C14), esophagus (C15), stomach (C16), colon and rectum (C18-C20), liver and intrahepatic bile duct (liver) (C22), gallbladder and other parts of the biliary tract (gallbladder) (C23-C24), pancreas (C25), larynx (C32), lung and bronchus (lung) (C33-C34), breast (C50), cervix uteri (C53), corpus uteri (C54), ovary (C56), prostate (C61), testis (C62), kidney (C64), bladder (C67), brain and central nervous system (C70-C72), thyroid (C73), Hodgkin lymphoma (C81), non-Hodgkin lymphoma (C82-C86, C96), multiple myeloma (C90), leukemia (C91-C95), and other and ill defined.
Population data from 1993 to 2018 were obtained from the resident registration population, reported by Statistics Korea. Data on the mid-year population, as of July 1 of the respective year, were analyzed. For the year 2018, however, we used population data as of December 31, 2017, because mid-2018 resident registration population was not yet available at the time of analysis.
Linear regression models [6] were used to assess time trends and projections. Firstly, we first performed a Joinpoint regression analysis on the data available to detect the year Includes the gallbladder and other/unspecified parts of the biliary tract, c)
Includes the lung and bronchus. We chose the number of joinpoint in order to have least four data points between consecutive joinpoints. Secondly, to predict age-specific cancer rates, a linear regression model was fitted to age-specific rates by 5-year age groups against observed years based on observed cancer incidence data of the latest trend. Finally, we multiply the projected age-specific rates by the age-specific population to get the projected cancer cases and deaths of the year 2018. We summarized the results by using crude rates (CRs) and age-standardized rates (ASRs) of cancer incidence and mortality. ASRs were standardized using the world standard population [8] and expressed per 100,000 persons.
Results

Incidence
A total of 204,909 new cancer cases are anticipated in 2018 (Table 1, Fig. 1 ), with more male (n=112,275) than female (n=92,634) of cancer patients expected.
The projected CRs per 100,000 of all sites combined in 2018 are projected to be 433.8 and 359.7 in men and women, respectively ( (Fig. 1) .
The five most common cancer sites expected in 2018 by sex and age group are shown in Table 3 . Leukemia and thyroid cancer are expected to be the most common forms of cancer in both genders for the 0-14 and 15-34 age groups. Stomach Includes the lung and bronchus. cancer is predicted to be the most prevalent in men aged 35-64 years, while lung cancer is expected to be more frequent in men aged 65 and over. Breast cancer is predicted to be the most common cancer in women 35-64 years of age, whereas colorectal cancer is expected to be the most prevalent in women aged 65 and over. These projections indicate that the incidences of stomach, lung, liver, colorectal and prostate cancers will increase gradually with age for men (Fig. 2) . In women, the age-specific incidence rates of stomach, colorectal, liver, lung and cervical cancers denote a rising trend in these cancers with age; however, the incidence of breast and thyroid cancer in women is expected to level off after 40s.
Mortality
It is estimated that 82,155 cancer deaths will occur in Korea during 2018 (Table 1, Fig.1 ). The projected CRs per 100,000 Includes the liver and intrahepatic bile duct, c)
Includes the gallbladder and other/unspecified parts of the biliary tract. Includes the lung and bronchus. 
Conclusion
A total of 204,909 new cancer cases and 82,155 cancer deaths are expected to occur in Korea during 2018. The lung cancer is predicted to the most common cancer among male, followed by stomach, colorectal, liver, and prostate cancers. Lung, liver, colorectal, stomach, and pancreatic cancers are expected to be the most common causes of cancer deaths among men. In women, the five leading primary sites are expected to be the breast, colorectal, stomach, thyroid, and lung cancers are anticipated to be the most prevalent, while lung, colorectal, pancreatic, liver, and breast cancers are projected to be the most common causes of cancer-related deaths.
Cancer is currently one of the foremost public health concerns in Korea. Although cancer rates are anticipated to decrease somewhat, but burden of most of cancers will continue to grow with the aging of its population. The current projections of cancer incidence and mortality for 2018 represent an important resource for planning and evaluation of cancer-control programs. As the estimates in this study are model-based, these results should be interpreted with caution. Especially, incidence of some cancers, such as stomach, colorectum and thyroid, started to decrease from early 2010s. So recent trends of those cancers contained only five or six data points, therefore their estimates could be unstable.
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